LEGN

Legend Biotech Corp

• TipRanks·19m ago

  RBC Capital Sticks to Their Buy Rating for Legend Biotech (LEGN)

• Seeking Alpha·1d ago

  Healthcare quant check: RLAY and TNGX lead Seeking Alpha’s top picks ahead of Q1 earnings

• Simply Wall St·3d ago

  Legend Biotech (LEGN) Is Up 13.9% After CARVYKTI Record Sales And REMS Removal News – Has The Bull Case Changed?

• Simply Wall St·5d ago

  Assessing Legend Biotech (LEGN) Valuation After Recent Share Price Rebound From Longer Term Weakness

• NASDAQ·5d ago

  We Did The Math GXC Can Go To $124

• TipRanks·6d ago

  Legend Biotech Earnings Call Highlights CARVYKTI Momentum

• Simply Wall St·6d ago

  Is Legend Biotech (LEGN) Pricing Reflect Its Value After Recent Share Price Rebound?

• Reuters·03/30 07:35

  U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan

• Reuters·03/30 03:22

  LEGEND BIOTECH CORP <LEGN.O>: PIPER SANDLER CUTS TARGET PRICE TO $64 FROM $78

• TipRanks·03/28 02:03

  Legend Biotech CEO Makes Notable Insider Move in Latest Stock Transaction

• Simply Wall St·03/27 07:06

  A Look At Legend Biotech (LEGN) Valuation As Investor Momentum Appears To Fade

• Barron‘s·03/25 17:10

  Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition Targets

• NASDAQ·03/20 14:50

  iShares MSCI Emerging Markets Asia ETF Experiences Big Outflow

• Reuters·03/18 23:03

  Legend Biotech files Form 3 as director Meng Robin reports no beneficial ownership securities

• Reuters·03/18 23:01

  Legend Biotech files Form 3 as Director Peter Salovey reports 26,766 ordinary shares